Press Releases
Pharmacy Times Reveals Pharmacists’ OTC Favorites
The 2014 OTC Guide supplement issue, website, and mobile app, touted on the TODAY show, announce the most recommended OTC products in more than 150...
Press Releases
Astellas Details Pipeline Progress at R&D Meeting
Astellas today announced progress on the Company's efforts to reshape its research framework at its R&D meeting held in Tokyo on July 10. The meeting...
Press Releases
Weight-Loss Surgery, Prescriptions More Satisfying for Obese Patients
Obese patients who underwent surgery or took medications to lose weight were more satisfied with their results than those who made lifestyle changes.
Nearly 60% of...
Press Releases
Japan Approves- Oral, Interferon and Ribavirin Free Hepatitis C Treatment and others
Offers new treatment option for genotype 1 HCV patients in Japan who are interferon-ineligible/intolerant, or did not previously respond to treatment Japanese HCV patients in...
Press Releases
genOway offers industry scientists immediate access to EUCOMM conditional KO mouse models
genOway guarantees freedom to operate (FTO) and offers important gains in conditional knockout development time for industry scientists
Lyon, France, July 2, 2014 - genOway (Alternext-NYSE...
Press Releases
Cancer research departments need to think beyond checkpoint inhibitors
Cancer immunotherapy research departments need to break their obsession with the latest flavour of the month - checkpoint inhibitors - and concentrate more on combining...
Press Releases
Provepharm and Dr Franz Kohler Chemie partner to provide Methylthioninium chloride Proveblue solution for injection to Germany
Proveblue(R) is the methylthioninium chloride or Methylene Blue active substance patented by Provepharm, compliant with current European Pharmacopeia standards Provepharm, a French...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.